NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

If science is to reclaim credibility, it must be seen interrogating its own failures, not shielding them. That is ...

At one of the largest cancer conferences in the world, researchers spoke with unusual boldness about advocating for their ...

Blood from a snake enthusiast who's been bitten hundreds of times aided the search for a universal snakebite treatment ...

Millipore Sigma, one of the largest suppliers of medical research products, will start adding a temporary tariff surcharge to ...

WASHINGTON — President Trump on Friday proposed massive cuts to the federal government’s health agencies in his 2026 budget ...

At Stanford’s Drug Discovery Symposium, biotech executives spoke openly about how the scientific ecosystem is now in jeopardy ...

In STAT's AACR Recap, reporters Matthew Herper and Angus Chen discussed the mood and highlights of one of the world's largest ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

A NIH policy change on funding of foreign scientists is far more sweeping than described in a Thursday announcement ...